233 related articles for article (PubMed ID: 31358545)
1. ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma.
Calderaro J; Meunier L; Nguyen CT; Boubaya M; Caruso S; Luciani A; Amaddeo G; Regnault H; Nault JC; Cohen J; Oberti F; Michalak S; Bouattour M; Vilgrain V; Pageaux GP; Ramos J; Barget N; Guiu B; Paradis V; Aubé C; Laurent A; Pawlotsky JM; Ganne-Carrié N; Zucman-Rossi J; Seror O; Ziol M
Clin Cancer Res; 2019 Oct; 25(19):5859-5865. PubMed ID: 31358545
[TBL] [Abstract][Full Text] [Related]
2. Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.
Ziol M; Poté N; Amaddeo G; Laurent A; Nault JC; Oberti F; Costentin C; Michalak S; Bouattour M; Francoz C; Pageaux GP; Ramos J; Decaens T; Luciani A; Guiu B; Vilgrain V; Aubé C; Derman J; Charpy C; Zucman-Rossi J; Barget N; Seror O; Ganne-Carrié N; Paradis V; Calderaro J
Hepatology; 2018 Jul; 68(1):103-112. PubMed ID: 29281854
[TBL] [Abstract][Full Text] [Related]
3. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
[TBL] [Abstract][Full Text] [Related]
4. Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
Mulé S; Galletto Pregliasco A; Tenenhaus A; Kharrat R; Amaddeo G; Baranes L; Laurent A; Regnault H; Sommacale D; Djabbari M; Pigneur F; Tacher V; Kobeiter H; Calderaro J; Luciani A
Radiology; 2020 Jun; 295(3):562-571. PubMed ID: 32228294
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypes and Tumor Immune Microenvironment in Hepatocellular Carcinoma With Macrotrabecular Massive and Vessels Encapsulating Tumor Clusters.
Akiba J; Nakayama M; Kondo R; Kusano H; Ogasawara S; Mihara Y; Tanigawa M; Tsutsui K; Yano Y; Miyazaki D; Tokisawa S; Mitsuhashi T; Nomura H; Sanada S; Sakai H; Hisaka T; Yano H
In Vivo; 2024; 38(2):640-646. PubMed ID: 38418151
[TBL] [Abstract][Full Text] [Related]
6. Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization.
Rhee H; Nahm JH; Kim H; Choi GH; Yoo JE; Lee HS; Koh MJ; Park YN
Mod Pathol; 2016 Sep; 29(9):1038-49. PubMed ID: 27312064
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma.
Liu LL; Zhang SW; Chao X; Wang CH; Yang X; Zhang XK; Wen YL; Yun JP; Luo RZ
Cancer Immunol Immunother; 2021 Feb; 70(2):417-429. PubMed ID: 32770259
[TBL] [Abstract][Full Text] [Related]
8. A morpho-molecular prognostic model for hepatocellular carcinoma.
Srivastava S; Wong KF; Ong CW; Huak CY; Yeoh KG; Teh M; Luk JM; Salto-Tellez M
Br J Cancer; 2012 Jul; 107(2):334-9. PubMed ID: 22713659
[TBL] [Abstract][Full Text] [Related]
9. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
[TBL] [Abstract][Full Text] [Related]
10. Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis.
Choi J; Chung T; Rhee H; Kim YJ; Jeon Y; Yoo JE; Noh S; Han DH; Park YN
Gut Liver; 2019 Jan; 13(1):83-92. PubMed ID: 29938458
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma.
Feng Y; Hu Y; Mao Q; Guo Y; Liu Y; Xue W; Cheng S
J Int Med Res; 2019 Feb; 47(2):569-579. PubMed ID: 30318967
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and Prognostic Ability of Contrast-Enhanced Unltrasound and Biomarkers in Hepatocellular Carcinoma Subtypes.
Xu W; Huang B; Zhang R; Zhong X; Zhou W; Zhuang S; Xie X; Fang J; Xu M
Ultrasound Med Biol; 2024 Apr; 50(4):617-626. PubMed ID: 38281888
[TBL] [Abstract][Full Text] [Related]
13. Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma.
Feng Z; Li H; Zhao H; Jiang Y; Liu Q; Chen Q; Wang W; Rong P
Radiology; 2021 Jul; 300(1):219-229. PubMed ID: 33973839
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
[TBL] [Abstract][Full Text] [Related]
15. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.
Calderaro J; Petitprez F; Becht E; Laurent A; Hirsch TZ; Rousseau B; Luciani A; Amaddeo G; Derman J; Charpy C; Zucman-Rossi J; Fridman WH; Sautès-Fridman C
J Hepatol; 2019 Jan; 70(1):58-65. PubMed ID: 30213589
[TBL] [Abstract][Full Text] [Related]
16. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
17. 3'UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma.
Hua KT; Liu YF; Hsu CL; Cheng TY; Yang CY; Chang JS; Lee WJ; Hsiao M; Juan HF; Chien MH; Yang SF
Sci Rep; 2017 Jun; 7(1):4466. PubMed ID: 28667334
[TBL] [Abstract][Full Text] [Related]
18. CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma.
Feng Z; Li H; Liu Q; Duan J; Zhou W; Yu X; Chen Q; Liu Z; Wang W; Rong P
Radiology; 2023 Apr; 307(1):e221291. PubMed ID: 36511807
[TBL] [Abstract][Full Text] [Related]
19. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma.
Kang YH; Ji NY; Lee CI; Lee HG; Kim JW; Yeom YI; Kim DG; Yoon SK; Kim JW; Park PJ; Song EY
Amino Acids; 2011 Mar; 40(3):1003-13. PubMed ID: 20821239
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced NIPP1 activation enhances metastatic potential and predicts poor prognosis in hepatocellular carcinoma.
Huang Y; Tao Y; Hu K; Lin F; Li X; Feng T; Wang ZM
Tumour Biol; 2016 Nov; 37(11):14903-14914. PubMed ID: 27644248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
